These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11784661)

  • 1. Macrolide treatment after coronary stent placement.
    Arzt M; Pfeifer M; Holmer S; Riegger G
    Lancet; 2001 Dec 22-29; 358(9299):2168-9. PubMed ID: 11784661
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial treatment of multiple sclerosis.
    Stratton CW; Wheldon DB
    Infection; 2007 Oct; 35(5):383-5; author reply 386. PubMed ID: 17882356
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
    Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
    Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia pneumoniae and acute coronary syndrome.
    Wong BY; Gnarpe J
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16079381
    [No Abstract]   [Full Text] [Related]  

  • 9. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cough syncope caused by a possible Chlamydia pneumoniae pneumonia].
    Cinotti R; Moubarak G; Gervais R; Mabo P
    Rev Med Interne; 2009 Sep; 30(9):809-11. PubMed ID: 19586690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early carotid atherosclerosis and Chlamydia pneumoniae seropositivity: are there arguments to treat with antibiotics?
    Ieven MM; Hoymans VY; Bosmans JM
    Circulation; 2004 Aug; 110(7):e74-5; author reply e74-5. PubMed ID: 15313965
    [No Abstract]   [Full Text] [Related]  

  • 13. [Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease].
    Skochko OV; Kaĭdashev IP
    Lik Sprava; 2012; (5):72-86. PubMed ID: 23534274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics and coronary heart disease.
    Modest GA; Kaufmann J
    JAMA; 2004 Jan; 291(3):302; author reply 303. PubMed ID: 14734586
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive disease.
    Wiesli P; Schulthess G
    Circulation; 2002 Dec; 106(25):e226; author reply e226. PubMed ID: 12485976
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlamydia infections in neurology].
    Woessner R; Treib J
    Dtsch Med Wochenschr; 2001 Feb; 126(6):153-5. PubMed ID: 11233885
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia pneumoniae and acute coronary syndrome.
    Paul M; Fraser A; Leibovici L
    N Engl J Med; 2005 Aug; 353(5):525-8; author reply 525-8. PubMed ID: 16080248
    [No Abstract]   [Full Text] [Related]  

  • 18. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

  • 19. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics and coronary heart disease.
    Nieto FJ
    JAMA; 2004 Jan; 291(3):302-3; author reply 303. PubMed ID: 14734587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.